Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Beretta Craft-Coffman

Physician Assistant, Surgical Canton, GA Physician Assistant

NPI 1285601880 CMS profile 11007954

125 Oakside Ct Ste 102, Canton, GA 30114

Open in the dashboard

General payments

$29,780

71 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Beretta Craft-Coffman of Canton, GA is reported in the CMS Open Payments database as having received $29,780 across 71 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $26,118 45
2024 General $661 10
2023 General $558 9
2022 General $2,349 5
2021 General $93 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Beretta Craft-Coffman
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Beretta Craft-Coffman were reported at $26,118. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Beretta Craft-Coffman Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $93 $111 $36–$285 $132
2022 $2,349 $126 $44–$350 $149
2023 $558 $137 $47–$355 $160
2024 $661 $146 $49–$384 $164
2025 $26,118 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Smith+Nephew, Inc. $22,770 42 payments
  2. Vericel Corporation $6,000 15 payments
  3. Avita Medical Americas, LLC $587 6 payments
  4. PolyMedics Innovations Inc $115 1 payment
  5. Medline Industries, Inc. $108 1 payment
  6. Trevena, Inc. $80 1 payment
  7. Acera Surgical, Inc. $43 1 payment
  8. Mallinckrodt Hospital Products Inc. $30 1 payment
  9. Avanos Medical $19 1 payment
  10. Kerecis Limited $16 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,150 5 payments
  2. Consulting Fee $8,875 5 payments
  3. Travel and Lodging $6,031 21 payments
  4. Food and Beverage $2,710 39 payments
  5. Education $15 1 payment
Products named General payments · program years 2021–2025
  1. COLLAGENASE SANTYL $20,076 25 payments
  2. OASIS Extra Cellular Matrix $17,087 29 payments
  3. ACTICOAT 4" X 4" $15,200 23 payments
  4. Versajet $11,437 22 payments
  5. EPICEL (CULTURED EPIDERMAL AUTOGRAFTS) $5,725 11 payments
  6. BIOBRANE $4,750 15 payments
  7. Nexobrid $3,574 10 payments
  8. OASIS MICRO $3,300 1 payment
  9. OASIS Extra Cellular Matrix $3,300 1 payment
  10. STRAVIX PL $696 1 payment
  11. Other $1,344 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$8,376

Medicare's payments for the services billed

Medicare patients

82

Average age 67

Services billed

397

38 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 65%
Chronic kidney disease 56%
Arthritis 50%
Heart failure 48%
Ischemic heart disease 40%
Depression 38%
Atrial fibrillation 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

71 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record